John you XXXX steps take us our review will review for our in then our And and achieve XXXX to joining success and drive you Thanks, up for XXXX fourth in performance future. I the we took thank predictable Mark, we On set growth today’s the the I and call, beyond. discuss and us. guidance. in guidance all quarter financial will will will to tell actions profitable
of worldwide and XXXX, number which XXXX and are discharges. result installed our a top hospitals of COVID, base gold our of doubled in doubled respiratory we As the the X,XXX U.S. terms during accounts,
After was difficult years to what volatility, two COVID it look would XXXX predict of like.
COVID to dramatically. As hospitalizations from respiratory decreased an transitioned disease, disease respiratory a COVID-related lower upper
all XXXX. needs time, in derisking these operating addressed At the up and devoted lower customer the reduced gross Throughout sheet. with saw business considerable success effort us same and margins issues us have constrained our and left we for a we meet to unsustainable setting XXXX, expenditures revenue, structure balance and capital to cost
to throughout areas of focus return majority to key and our year of disposable One has revenue gross our highest revenue it the predictable growth, margin. as the been the represents carries
accounts. We this our have on by gold done focusing
and In these education additional medical been have delivering and areas high expanding care accounts, we into training. quality
which represent rates, these sold box recovered. turn disposables steadily a have seen efforts, of month U.S. As per result we disposable per
had usual. the three-year in pre-COVID arriving XX% In quarter, we part earlier to fourth average of flu than historical due our
second disposable was from of turn the U.S. up XX% XX% the quarter fourth rate in Our quarter. XX% in and third quarter
represents launch Flow the Plus. also a X.X. Precision our upgrade the on of platform executing are We HVT over major This next-generation
fleets this lot see product beginning interest and a makes second, of existing the transport replace also allows time. in has the There blower, a incorporates these which First, wall of patients easier training and air. a between customers it to number that areas. newer in And we be their it it hospital it to don’t use care to therefore launch easier requires of have devices. since less It’s been are with used built-in to areas
to During been quarter, that moved our to am and I is validated. margins. new report have we VapoMax our pleased efforts improve certified. gross continued lines All our production the [ph] facility
assumptions inventory. intact of all and product cost are and we our it putting building are Importantly, into
We see cost needs. the these that meet products lower during will begin built we to through as work all the impact customer we cost to high of inventory COVID
recently will focus XXXX. and balance The Another balance convert in we inventory in financial shape have of flexibility. key sheet. $XX area the our equity improved by cash $XX million million raise to good presently is of end the balance and now We of sheet XXXX completed sheet a our expected was on
facility also election SLR our XXXX the to our financial cash the saving cash of of portion pick expenditures covenant to expense, minimum our reduce We interest covenants, add up $X debt ability a potentially at XXXX restructured million. to our reset and
operating get of Between this conversion the the our expect expenses improvements we gross positive additional the our cash to end relocation to manufacturing we have us payments, our interest of equity the from necessary from inventory to believe adjusted year. in EBITDA the to ability raise, to recent and our reductions the capital Mexico, of margin pick cash, we by
we decreased in million. level cash of set XXXX, $XX in or with versus XXXX, of heavily to also focused levels on to approximately expenses pre-COVID the reducing operating During XXXX expenses to $XX million by million operating XXXX. stage expenses operating in million cash Cash XXXX pre-COVID deliver $XX.X $XX
R&D a established investments Vapotherm back we year, RespirCare, our worldwide and R&D portion organization, Singaporean commercial a brought center. in right-sized won in the Government and to our Access During offset from R&D our the in-house newly stopped grant commercial new efforts of
for call quarter. results who now will financial John over the will to this the review turn I